ロード中...
Enhanced efficacy of histone deacetylase inhibitor combined with bromodomain inhibitor in glioblastoma
BACKGROUND: Glioblastoma (GBM) is the most common and most malignant primary brain cancer in adults. Despite multimodality treatment, the prognosis is still poor. Therefore, further work is urgently required to discover novel therapeutic strategies for GBM treatment. METHODS: The synergistic effects...
保存先:
| 出版年: | J Exp Clin Cancer Res |
|---|---|
| 主要な著者: | , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
BioMed Central
2018
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6167847/ https://ncbi.nlm.nih.gov/pubmed/30285808 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13046-018-0916-y |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|